Oppenheimer (OPY) Receiving Favorable Press Coverage, Accern Reports
News articles about Oppenheimer (NYSE:OPY) have trended positive this week, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Oppenheimer earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 44.2385905034266 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Separately, ValuEngine cut shares of Oppenheimer from a “buy” rating to a “hold” rating in a report on Friday, December 1st.
Oppenheimer (NYSE OPY) opened at $26.75 on Friday. The firm has a market cap of $351.95, a P/E ratio of -1,336.83 and a beta of 1.53. Oppenheimer has a 1-year low of $15.10 and a 1-year high of $29.00. The company has a quick ratio of 0.64, a current ratio of 1.22 and a debt-to-equity ratio of 0.39.
COPYRIGHT VIOLATION NOTICE: “Oppenheimer (OPY) Receiving Favorable Press Coverage, Accern Reports” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2018/01/13/oppenheimer-opy-receiving-favorable-press-coverage-accern-reports.html.
Oppenheimer Holdings Inc is a middle-market investment bank and service broker-dealer. The Company is engaged in a range of activities in the securities industry, including retail securities brokerage, institutional sales and trading, investment banking, research, market-making, trust services, and investment advisory and asset management services.
Receive News & Stock Ratings for Oppenheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oppenheimer and related stocks with our FREE daily email newsletter.